Jesus Gaffney, V. C.M.M. Almeida, A. Rodrigues, E. Ferreira, M.J. Benoliel, V.V. Cardoso, Occurrence of pharmaceuticals in a water supply system and related human health risk assessment, Water Res. 72 (2015) 199–208. https://doi.org/10.1016/j.watres.2014.10.027.
de Jongh, C.M. P.J.F. Kooij, P. de Voogt, T.L. ter Laak, Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface waters and drinking water, Sci. Total Environ. 427–428 (2012) 70–77. https://doi.org/10.1016/j.scitotenv.2012.04.010.
Deo, R.P., Pharmaceuticals in the surface water of the USA: A review. Curr. Environ. Health Rpt. 1, 113-122, 2014. doi:10.1007/s40572-014-0015-y
Du. J, Fan. Y, and Qian. X (2015). Occurrence and behaviour of pharmaceuticals in sewage treatment lants in eastern China. Font Environ. Sci. Eng. 9(4): 725–730.
Fabbri, E., Franzellitti, S., Human pharmaceuticals in the marine environment: focus on exposure and biological effect in animal species. Environ. Toxicol. Chem. 35(4), 799-812, 2016. doi:10.1002/etc.3131
Fantuzzi, G., Aggazzotti, G., Righi, E., Predieri, G., Castiglioni, S., Riva, F. and Zuccato, E., 2018. Illicit drugs and pharmaceuticals in swimming pool waters. Science of the Total Environment, 635, pp.956–963.
Farshad, A, A., Enferadi, M., Bakand, S., Orak, R.J., Mirkazemi, R., Penicillin dust exposure and penicillin resistance among pharmaceutical workers in Tehran, Iran. Int. J. Occup. Environ. Health 22(3), 218-223, 2016, doi: 10.1080/10773525.2016.1201238
Fent, K., Weston, A.A., Caminada, D., Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 76, 122–59, 2006.
Foureaux, A.F.S. E.O. Reis, Y. Lebron, V. Moreira, L. V. Santos, M.S. Amaral, L.C. Lange, Rejection of pharmaceutical compounds from surface water by nanofiltration and reverse osmosis, Sep. Purif. Technol. (2019). https://doi.org/10.1016/j.seppur.2018.11.018.
Gaw, S., Thomas, K.V., Hutchinson, T.H., Sources, impacts and trends of pharmaceuticals in the marine and coastal environment. Phil. Trans. R. Soc. B. 369, 20130572, 2014. doi:10.1098/rstb.2013.0572
Gros. M, Rodriguez-Mozaz. S, and Barcelό. D (2012). Fast and comprehensive multi-residue analysis of a broad range of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-high-performance liquid chromatography coupled to quadupole-linear ion trap tandem mass spectrometry. Journal of chromatography A. 1248: 104–121.
Gwenzi, W., Chaukura, N., Noubactep, C., Mukome, F.N., 2017. Biochar-based water treatment systems as a potential low-cost and sustainable technology for clean water provision. J. Environ. Manag. 197, 732–749.
Heron, R.J.L., Pickering, F.C., Health effects of exposure to active pharmaceuticals ingredients (APIs). Occup. Med. 53, 357-362, 2003. doi:10.1093/kqg115
Houtman, C.J., Emerging contaminants in surface waters and their relevance for the production of drinking water in Europe. J. Integrative Sci. 7(4), 271–295, 2010. doi:10.1080/1943815X.2010.511648
Houtman, C.J. J. Kroesbergen, K. Lekkerkerker-Teunissen, J.P. van der Hoek, Human health risk assessment of the mixture of pharmaceuticals in Dutch drinking water and its sources based on frequent monitoring data, Sci. Total Environ. (2014). https://doi.org/10.1016/j.scitotenv.2014.07.022.
International Agency for Research on Cancer (2012) Pharmaceuticals: A review of human carcinogens. IARC Monographs on the evaluation of carcinogenic risks to humans Viol 100A, IARC, Leon, 2012.
Jayasuriya, D.C., Regulation of pharmaceuticals in developing countries: legal issues and approaches. WHO, Geneva, 1985.
Jones, O.A.H., Voulvoulis, N., Lester, J.N., Potential ecological and human health risks associated with the presence of pharmaceutically active compounds in the aquatic environment. Crit. Rev. Toxicol. 34, 335–50, 2004.
Kaczala, F., Blum, S.E., The occurrence of veterinary pharmaceuticals in the environment. A review. Curr. Analyt. Chem. 12(3), 169–182, 2016.
Kay. P, Hughes. S. R, Ault. J. R, Ashcroft. A. E and Brown. L. E (2017). Widespread, routine occurrence of pharmaceuticals in sewage effluent, combined sewer overflows and receiving waters. Environmental pollution 220 pp. 1447–1455.
Kibuye, F.A., Gall, H.E., Elkin, K.R., Swistock, B., Veith, T.L., Watson, J.E., Elliot, H.A., Occurrence, concentrations and risks of pharmaceutical compounds in private wells in central Pennsylvania. J. Environ. Qual. 48, 1057–1066, 2019. doi:10.2134/jeq2018.08.0301
Koopaei, N.N., Abdollahi, M., Health risks associated with pharmaceuticals in wastewater. DARU J. Pharm. Sci. 25, 9, 2017. doi:10.1186/s40199-017-0176-y
K’oreje. K. O, Dermeestere. K, DeWisdaere. P, Vergeyst. L, Dewulf. J and Van Langenhove. H (2012). From multi-residue screening to target analysis of pharmaceuticals in water: development of new approach based on magnetic sector mass spectrometry and application in the Nairobi River basin Kenya. Science of the Total Environment, 437, pp.153–164.
Kumar, A., Chang, B., Xagoraraki, I., Human health risk assessment of pharmaceuticals in water: Issues and challenges ahead. Int. J. Environ. Res. Public Health 7, 3929-3953, 2010. doi:10.3390/ijerph7113929
Kumar, A. I. Xagoraraki, Human health risk assessment of pharmaceuticals in water: An uncertainty analysis for meprobamate, carbamazepine, and phenytoin, Regul. Toxicol. Pharmacol. 57 (2010) 146–156. https://doi.org/10.1016/j.yrtph.2010.02.002.
Kümmerer, K., Pharmaceuticals in the environment - A brief summary. In: Pharmaceuticals in the Environment, K, Kümmerer (Ed.), pp. 3-21, Springer, Berlin, Heidelberg, 2008. doi.org/10.1007/978-3-540-74664-5_23
Kümmerer, K., Pharmaceuticals in the environment. Annu. Rev. Environ. Resour. 35, 57–75, 2010. doi: 10.1146/annurev-environ-052809-161223
Küster, A., Adler, N., Pharmaceuticals in the environment: scientific evidence of risks and its regulation. Phil. Trans. R. Soc. B. 369, 20130587, 2014. doi:10.1098/rstb.2013.0587
Lagesson,. A, Fahlman, J., Brodin, T., Fick, J., Jonsson, M., Byström, P., Bioaccumulation of five pharmaceuticals at multiple trophic levels in an aquatic food web - Insights from a field experiment. Sci. Tot. Environ. 568, 208–215, 2016. doi:10.1016/j.scitotenv.2016.05.026
Letsinger, S., Kay, P., Comparison of priotisation schemes for human pharmaceuticals in the aquatic environment. Environ. Sci. Pollut. Res. 26, 3479-3491, 2019. doi:10.1007/a11356-018-3834-9
Leung, H.W., Jin, L., Wei, S., Tsui, M.M.P., Zhou, B., Jiao, L., Cheung, P.C., Chun, Y.K., Murphy, M.B., Lam, P.W.S., Pharmaceuticals in tap water: Human health risk assessment of proposed monitoring framework in China. Environ. Health Perspect. 121, 839-846, 2013. doi:10.1289/ehp.1206244
Li. M, Sun. Q, Li. Y, Lv. M, Lin. L, Wu. Y, Ashfaq. M and Yu. C (2016). Simultaneous analysis of 45 pharmaceuticals and personal care products in sludge by matrix solid-phase dispersion and liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 408: 4953–4964.
Li, N. K.W.K. Ho, G.G. Ying, W.J. Deng, Veterinary antibiotics in food, drinking water, and the urine of preschool children in Hong Kong, Environ. Int. (2017). https://doi.org/10.1016/j.envint.2017.08.014.
Licona, K.P.M. L.R. d. O. Geaquinto, J. V. Nicolini, N.G. Figueiredo, S.C. Chiapetta, A.C. Habert, L. Yokoyama, Assessing potential of nanofiltration and reverse osmosis for removal of toxic pharmaceuticals from water, J. Water Process Eng. (2018). https://doi.org/10.1016/j.jwpe.2018.08.002.
Liu,